Penicillin Antibiotics in Modern Therapy: Efficacy, Safety, and Resistance Trends
Abstract
Background: Penicillin, a cornerstone of β-lactam antibiotics, remains widely used for treating bacterial infections due to its broad activity and established safety profile. However, rising antimicrobial resistance and pharmacokinetic limitations necessitate careful therapeutic selection.
Aim: This review evaluates the clinical efficacy, safety, resistance trends, pharmacology, and administration considerations of penicillin in modern practice.
Methods: A comprehensive literature synthesis was conducted, analyzing FDA-approved indications, mechanisms of action, pharmacokinetics, adverse effects, drug interactions, and patient-specific considerations.
Results: Penicillin retains effectiveness against gram-positive cocci, select gram-negative organisms, and anaerobes, with expanded-spectrum derivatives addressing resistance challenges. FDA-approved uses include anthrax, syphilis, meningitis, and streptococcal infections. Mechanistically, penicillin inhibits peptidoglycan cross-linking via irreversible binding to penicillin-binding proteins, leading to bacterial lysis. Pharmacokinetics reveal oral acid stability for penicillin V, while parenteral formulations ensure systemic exposure for penicillin G. Adverse effects range from mild gastrointestinal symptoms to severe hypersensitivity and rare neurotoxicity. Resistance, primarily mediated by β-lactamase production and altered permeability, underscores the need for β-lactamase inhibitors and stewardship strategies.
Conclusion: Despite resistance concerns, penicillin remains integral to antimicrobial therapy when guided by susceptibility testing and individualized dosing. Its favorable safety profile supports use in pregnancy, pediatrics, and lactation, provided contraindications are excluded. Interprofessional collaboration and patient education are essential to optimize outcomes and minimize complications.
Full text article
References
Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. The New England journal of medicine. 1994 Aug 11:331(6):377-82
Herman DJ, Gerding DN. Antimicrobial resistance among enterococci. Antimicrobial agents and chemotherapy. 1991 Jan:35(1):1-4
Spratt BG, Cromie KD. Penicillin-binding proteins of gram-negative bacteria. Reviews of infectious diseases. 1988 Jul-Aug:10(4):699-711
Perry CM, Markham A. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs. 1999 May:57(5):805
Kache PA, Person MK, Seeman SM, McQuiston JR, McCollum J, Traxler RM. Rat-Bite Fever in the United States: An Analysis Using Multiple National Data Sources, 2001-2015. Open forum infectious diseases. 2020 Jun:7(6):ofaa197. doi: 10.1093/ofid/ofaa197.
Harcourt BH, Anderson RD, Wu HM, Cohn AC, MacNeil JR, Taylor TH, Wang X, Clark TA, Messonnier NE, Mayer LW. Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States. Open forum infectious diseases. 2015 Sep:2(3):ofv117. doi: 10.1093/ofid/ofv117.
Dunaway SB, Maxwell CL, Tantalo LC, Sahi SK, Marra CM. Neurosyphilis Treatment Outcomes After Intravenous Penicillin G Versus Intramuscular Procaine Penicillin Plus Oral Probenecid. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Jul 11:71(2):267-273. doi: 10.1093/cid/ciz795.
Antibiotics in the treatment of periodontal disease: a guide for the general dental practitioner., Gillam DG,Turner W,, Primary dental journal, 2014 Aug
Wyber R, Taubert K, Marko S, Kaplan EL. Benzathine Penicillin G for the Management of RHD: Concerns About Quality and Access, and Opportunities for Intervention and Improvement. Global heart. 2013 Sep:8(3):227-34. doi: 10.1016/j.gheart.2013.08.011.
Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2015 Jun 5:64(RR-03):1-137
Fisher JF, Mobashery S. Constructing and deconstructing the bacterial cell wall. Protein science : a publication of the Protein Society. 2020 Mar:29(3):629-646. doi: 10.1002/pro.3737.
Gordon E, Mouz N, Duée E, Dideberg O. The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance. Journal of molecular biology. 2000 Jun 2:299(2):477-85
Espinosa-Gongora C, Jessen LR, Kieler IN, Damborg P, Bjørnvad CR, Gudeta DD, Pires Dos Santos T, Sablier-Gallis F, Sayah-Jeanne S, Corbel T, Nevière A, Hugon P, Saint-Lu N, de Gunzburg J, Guardabassi L. Impact of oral amoxicillin and amoxicillin/clavulanic acid treatment on bacterial diversity and β-lactam resistance in the canine faecal microbiota. The Journal of antimicrobial chemotherapy. 2020 Feb 1:75(2):351-361. doi: 10.1093/jac/dkz458.
Wolman AT, Gionfriddo MR, Heindel GA, Mukhija P, Witkowski S, Bommareddy A, Vanwert AL. Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics. Drug metabolism and disposition: the biological fate of chemicals. 2013 Apr:41(4):791-800. doi: 10.1124/dmd.112.049569.
Barker CI, Germovsek E, Sharland M. What do I need to know about penicillin antibiotics? Archives of disease in childhood. Education and practice edition. 2017 Feb:102(1):44-50. doi: 10.1136/archdischild-2015-309068.
Wilson RC, Arkell P, Riezk A, Gilchrist M, Wheeler G, Hope W, Holmes AH, Rawson TM. Addition of probenecid to oral β-lactam antibiotics: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy. 2022 Aug 25:77(9):2364-2372. doi: 10.1093/jac/dkac200.
Robbins N, Gilbert M, Kumar M, McNamara JW, Daly P, Koch SE, Conway G, Effat M, Woo JG, Sadayappan S, Rubinstein J. Probenecid Improves Cardiac Function in Patients With Heart Failure With Reduced Ejection Fraction In Vivo and Cardiomyocyte Calcium Sensitivity In Vitro. Journal of the American Heart Association. 2018 Jan 13:7(2):. doi: 10.1161/JAHA.117.007148.
Penicillins (1st Generation). LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012
Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, van de Beek D, Bleck TP, Garton HJL, Zunt JR. 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 Mar 15:64(6):e34-e65. doi: 10.1093/cid/ciw861.
Parker CM, Karchmer AW, Fisher MC, Muhammad KM, Yu PA. Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022 Oct 17:75(Suppl 3):S417-S431. doi: 10.1093/cid/ciac592.
Zoratti C, Moretti R, Rebuzzi L, Albergati IV, Di Somma A, Decorti G, Di Bella S, Crocè LS, Giuffrè M. Antibiotics and Liver Cirrhosis: What the Physicians Need to Know. Antibiotics (Basel, Switzerland). 2021 Dec 28:11(1):. doi: 10.3390/antibiotics11010031.
Smyth B, Jones C, Saunders J. Prescribing for patients on dialysis. Australian prescriber. 2016 Feb:39(1):21-4. doi: 10.18773/austprescr.2016.008.
Heikkilä AM, Erkkola RU. The need for adjustment of dosage regimen of penicillin V during pregnancy. Obstetrics and gynecology. 1993 Jun:81(6):919-21
. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797. Obstetrics and gynecology. 2020 Feb:135(2):e51-e72. doi: 10.1097/AOG.0000000000003668.
. Penicillin V. Drugs and Lactation Database (LactMed®). 2006
. Penicillin G. Drugs and Lactation Database (LactMed®). 2006
Abdulkader RCRM, Burdmann EA, Lebrão ML, Duarte YAO, Zanetta DMT. Aging and decreased glomerular filtration rate: An elderly population-based study. PloS one. 2017:12(12):e0189935. doi: 10.1371/journal.pone.0189935.
Bhattacharya S. The facts about penicillin allergy: a review. Journal of advanced pharmaceutical technology & research. 2010 Jan:1(1):11-7
Chow KM, Hui AC, Szeto CC. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2005 Oct:24(10):649-53
Finnigan NA, Rout P, Leslie SW, Bashir K. Allergic and Drug-Induced Interstitial Nephritis. StatPearls. 2024 Jan
Belum GR, Belum VR, Chaitanya Arudra SK, Reddy BS. The Jarisch-Herxheimer reaction: revisited. Travel medicine and infectious disease. 2013 Jul-Aug:11(4):231-7. doi: 10.1016/j.tmaid.2013.04.001.
Gaig P, Paniagua MJ. [Hoigne's syndrome]. Allergologia et immunopathologia. 2005 Jan-Feb:33(1):57-8
McNulty R, Kuchi N, Xu E, Gunja N. Food-induced methemoglobinemia: A systematic review. Journal of food science. 2022 Apr:87(4):1423-1448. doi: 10.1111/1750-3841.16090.
Ocampo PS, Lázár V, Papp B, Arnoldini M, Abel zur Wiesch P, Busa-Fekete R, Fekete G, Pál C, Ackermann M, Bonhoeffer S. Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrobial agents and chemotherapy. 2014 Aug:58(8):4573-82. doi: 10.1128/AAC.02463-14.
Ivanyuk A, Livio F, Biollaz J, Buclin T. Renal Drug Transporters and Drug Interactions. Clinical pharmacokinetics. 2017 Aug:56(8):825-892. doi: 10.1007/s40262-017-0506-8.
Levison ME, Levison JH. Pharmacokinetics and pharmacodynamics of antibacterial agents. Infectious disease clinics of North America. 2009 Dec:23(4):791-815, vii. doi: 10.1016/j.idc.2009.06.008.
Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile infection. Nature reviews. Disease primers. 2016 Apr 7:2():16020. doi: 10.1038/nrdp.2016.20.
Öbrink-Hansen K, Wiggers H, Bibby BM, Hardlei TF, Jensen K, Kragh Thomsen M, Brock B, Petersen E. Penicillin G Treatment in Infective Endocarditis Patients - Does Standard Dosing Result in Therapeutic Plasma Concentrations? Basic & clinical pharmacology & toxicology. 2017 Feb:120(2):179-186. doi: 10.1111/bcpt.12661.
Stewart Gt. Toxicity Of The Penicillins. Postgraduate medical journal. 1964 Dec:40(Suppl):SUPPL:160-9
Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. British journal of clinical pharmacology. 2011 Sep:72(3):381-93. doi: 10.1111/j.1365-2125.2011.03991.x.
Cusumano JA, Defrank A, Funk OG, Lerner P, Tanprayoon M, Vasa C, Mazo D. The Role of an Infectious Diseases Faculty Pharmacist and Pharmacy Students on an Antimicrobial Stewardship Team at a Community Non-teaching Hospital. Journal of pharmacy practice. 2024 Apr:37(2):335-342. doi: 10.1177/08971900221134648.
Authors
Copyright (c) 2025 Mashael Mannaa Bin Radhi Alanazi, Reem Alhamaidi Fahad Almutairi, Fahd Omar amer Alsahafi, Khalid Hamoud Alharbi, Mohammed Fahad Alotaibi, Hamad Bin Mohammed Bin Ali Aldawsari, Mohammed Murdi Abdullah Alqahtani, Al Anoud Abdullah Raheel Al Anzi, Mahasen Fawaza Alharbi, Watin Hutayl H. Al-Shammari, Nazek Sufug Nazal Alenazi, Mohammed Abdulrashid Abdulkarim Rajab, Mashael Saad Albshri

This work is licensed under a Creative Commons Attribution 4.0 International License.
